| abstract |
The present invention relates to a pharmaceutical composition for the prevention and treatment of bone metabolic disease, disease caused by oxidative stress, inflammatory disease comprising Schizandra extract.n n n The present invention includes the extract of Schizandra chinensis with bone mineralization and bone matrix protein synthesis, antioxidant, anti-inflammatory analgesic action, and direct or adjuvant therapy for the prevention and treatment of bone metabolic diseases, diseases caused by oxidative stress and inflammatory diseases Can be used asn n n The therapeutic agent of the present invention is a naturally-derived drug including an extract obtained from one of the herbal medicines, Schisandra chinensis, and it is preferable to replace the existing synthetic drugs because it has an excellent effect without showing various side effects of the existing synthetic drugs. To prevent and treat bone metabolic diseases, diseases caused by oxidative stress and inflammatory diseases can be provided. |